We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$1.22B
AUM Growth
+$126M
Cap. Flow
+$160M
Cap. Flow %
13.12%
Top 10 Hldgs %
9.33%
Holding
998
New
433
Increased
145
Reduced
138
Closed
273

Sector Composition

Rank Sector Weight
1 Healthcare 23.02%
2 Consumer Discretionary 17.09%
3 Industrials 12.79%
4 Financials 8.82%
5 Technology 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
51
Mondelez International
MDLZ
$80.7B
$5.82M 0.48%
+135,929
New +$5.71M
PZZA icon
52
Papa John's
PZZA
$1.03B
$5.7M 0.47%
+101,542
New +$6.32M
ABLX
53
DELISTED
Ablynx NV
ABLX
$5.66M 0.46%
+226,275
New +$5.11M
IMGN
54
DELISTED
Immunogen Inc
IMGN
$5.55M 0.45%
865,356
-93,489
-10% -$577K
ALGN icon
55
Align Technology
ALGN
$12.4B
$5.53M 0.45%
+24,896
New +$5.65M
MOS icon
56
The Mosaic Company
MOS
$7.24B
$5.53M 0.45%
+215,513
New +$4.95M
PF
57
DELISTED
Pinnacle Foods, Inc.
PF
$5.5M 0.45%
92,543
-17,155
-16% -$967K
FISV
58
Fiserv Inc
FISV
$28.9B
$5.5M 0.45%
+83,850
New +$5.41M
CRL icon
59
Charles River Laboratories
CRL
$11.4B
$5.49M 0.45%
50,125
+125
+0.3% +$13.6K
CAG icon
60
Conagra Brands
CAG
$7.43B
$5.47M 0.45%
145,321
+101,319
+230% +$3.6M
KREF
61
KKR Real Estate Finance Trust
KREF
$477M
$5.36M 0.44%
267,978
-30,437
-10% -$630K
RGNX icon
62
Regenxbio
RGNX
$610M
$5.28M 0.43%
158,687
+18,567
+13% +$559K
CSTM icon
63
Constellium
CSTM
$4B
$5.18M 0.42%
464,434
+356,558
+331% +$3.79M
MGP
64
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$5.17M 0.42%
177,546
+65,159
+58% +$1.91M
VFC icon
65
VF Corp
VFC
$6.92B
$5.17M 0.42%
+74,220
New +$4.9M
SIEN
66
DELISTED
Sientra, Inc.
SIEN
$5.15M 0.42%
36,640
-130
-0.4% -$18.9K
CGNX icon
67
Cognex
CGNX
$9.89B
$5.1M 0.42%
83,371
+28,425
+52% +$1.81M
PVLA
68
Palvella Therapeutics
PVLA
$2B
$5.1M 0.42%
8,438
-625
-7% -$291K
AIG icon
69
American International
AIG
$42.7B
$5.02M 0.41%
84,283
+29,468
+54% +$1.81M
SRPT icon
70
Sarepta Therapeutics
SRPT
$1.62B
$5.01M 0.41%
90,000
-109,789
-55% -$5.82M
ABBV icon
71
AbbVie
ABBV
$468B
$4.85M 0.4%
50,139
+41,139
+457% +$3.88M
FLIR
72
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$4.79M 0.39%
102,811
+96,908
+1,642% +$4.42M
GPMT
73
Granite Point Mortgage Trust
GPMT
$63.3M
$4.78M 0.39%
269,603
+49,321
+22% +$897K
TROX icon
74
Tronox
TROX
$976M
$4.71M 0.39%
+229,771
New +$5.6M
CLVS
75
DELISTED
Clovis Oncology, Inc.
CLVS
$4.71M 0.39%
69,240
+23,176
+50% +$1.62M

Similar funds

Schonfeld Strategic Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Schonfeld Strategic Advisors held 998 positions worth $1.22B, up 12% from $1.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Schonfeld Strategic Advisors deployed $160M of net new capital in Q4 2017, opening 433 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Aetna Inc, an estimated $12.6M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2017 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
  • Schonfeld Strategic Advisors added most to Dollar Tree in Q4 2017, an estimated $8.78M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $12.6M.
  • Schonfeld Strategic Advisors fully exited First Data Corporation in Q4 2017, selling an estimated $14.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 9.3% of its $1.22B portfolio in Q4 2017.
  • Schonfeld Strategic Advisors opened 433 new positions and closed 273 in Q4 2017.
  • Schonfeld Strategic Advisors's portfolio value rose 12% quarter-over-quarter to $1.22B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.